Xencor, Inc Other Comprehensive Income (Loss), Net of Tax
Xencor, Inc (XNCR) reported Other Comprehensive Income (Loss), Net of Tax of -$8.92 million for the 3-month period ending 2015-06-30, per its 10-Q filed 2015-08-05.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2015-08-05
- Xencor, Inc other comprehensive income (loss), net of tax for the quarter ending 2015-06-30 was -$8.92M.
- Xencor, Inc other comprehensive income (loss), net of tax for the quarter ending 2015-03-31 was -$6.48M.
- Xencor, Inc other comprehensive income (loss), net of tax for the quarter ending 2014-06-30 was -$5.04M.
- Xencor, Inc other comprehensive income (loss), net of tax for the quarter ending 2014-03-31 was -$3.75M.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month |
|---|---|---|
| 2015-06-30 | -$8.92M 10-Q · filed 2015-08-05 | -$15.40M 10-Q · filed 2015-08-05 |
| 2015-03-31 | -$6.48M 10-Q · filed 2015-05-05 | |
| 2014-06-30 | -$5.04M 10-Q · filed 2015-08-05 | -$8.79M 10-Q · filed 2015-08-05 |
| 2014-03-31 | -$3.75M 10-Q · filed 2015-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |